Indeed, a linkage between EGFR and ERα36 expression in carcinoma cells was determined, indicating that ERα36 influences the activation of extracellular signaling involved in EGFR/Src [16,44], probably through the interaction with membrane proteins of breast cancer cells. The gene discussed is SRC; the disease is carcinoma.